Neurogene Inc.
NGNEFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Neurogene Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Source: Neurogene Inc. — 10-K filed Mar 24, 2026
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 14 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 16, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | 2026-03-31 | 204,809 | $4.13M | SEC filing |
| ROYAL BANK OF CANADA | 2026-03-31 | 112 | $2K | SEC filing |
| Farther Finance Advisors, LLC | 2026-03-31 | 170 | $3.68K | SEC filing |
| Essential Partners LLC | 2026-03-31 | 20 | $403 | SEC filing |
| IFP Advisors, Inc | 2026-03-31 | 1 | $20 | SEC filing |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 2026-03-31 | 604 | $12.2K | SEC filing |
| Rock Springs Capital Management LP | 2026-03-31 | 104,339 | $2.1M | SEC filing |
| Nuveen, LLC | 2026-03-31 | 25,210 | $508K | SEC filing |
| AQR CAPITAL MANAGEMENT LLC | 2026-03-31 | 10,311 | $208K | SEC filing |
| EverSource Wealth Advisors, LLC | 2026-03-31 | 44 | $888 | SEC filing |
| Allworth Financial LP | 2026-03-31 | 30 | $605 | SEC filing |
| SBI Securities Co., Ltd. | 2026-03-31 | 125 | $2.52K | SEC filing |
| BAKER BROS. ADVISORS LP | 2026-03-31 | 991,691 | $20M | SEC filing |
| NISA INVESTMENT ADVISORS, LLC | 2026-03-31 | 63 | $1.27K | SEC filing |
| Truvestments Capital LLC | 2026-03-31 | 46 | $927 | SEC filing |
| Brevan Howard Capital Management LP | 2026-03-31 | 12,754 | $257K | SEC filing |
| Tower Research Capital LLC (TRC) | 2026-03-31 | 1,279 | $25.8K | SEC filing |
| Trails Edge Capital Partners, LP | 2026-03-31 | 782,787 | $15.8M | SEC filing |
| Mitsubishi UFJ Asset Management Co., Ltd. | 2026-03-31 | 7,994 | $161K | SEC filing |
| GREAT POINT PARTNERS LLC | 2026-03-31 | 500,000 | $10.1M | SEC filing |
Filer report history
Two reports per filer, as filed. No change is calculated, because the data on file cannot confirm that both reports describe the same security.
- Ameritas Investment Partners, Inc.: 1,009 shares reported 2025-12-31; 1,009 shares reported 2026-03-31.
- Police & Firemen's Retirement System of New Jersey: 2,013 shares reported 2025-12-31; 3,846 shares reported 2026-03-31.
- NATIONAL BANK OF CANADA /FI/: 8 shares reported 2025-12-31; 8 shares reported 2026-03-31.
- DEUTSCHE BANK AG\: 85,571 shares reported 2025-12-31; 106,255 shares reported 2026-03-31.
- MetLife Investment Management, LLC: 5,932 shares reported 2025-12-31; 5,932 shares reported 2026-03-31.
- ALPS ADVISORS INC: 12,721 shares reported 2025-12-31; 12,606 shares reported 2026-03-31.
- Virtus Investment Advisers, LLC: 12,716 shares reported 2025-12-31; 13,033 shares reported 2026-03-31.
- Legal & General Group Plc: 898 shares reported 2025-12-31; 898 shares reported 2026-03-31.
- Russell Investments Group, Ltd.: 856 shares reported 2025-12-31; 1,607 shares reported 2026-03-31.
- SIMPLEX TRADING, LLC: 62 shares reported 2025-12-31; 89 shares reported 2026-03-31.
- FMR LLC: 130,329 shares reported 2025-12-31; 382,647 shares reported 2026-03-31.
- UBS Group AG: 154,123 shares reported 2025-12-31; 185,679 shares reported 2026-03-31.
Showing the 12 most recent filer reports.
72 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Neurogene Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2025-05-14 · Cobb Stuart: Larger than 48 of the 51 other insider sales of Common Stock on file. SEC filing
- 2023-08-15 · BAKER JULIAN: Larger than 47 of the 48 other insider purchases of Common Stock on file. SEC filing
- 2023-02-02 · Patel Priti: Larger than all 51 other insider sales of Common Stock on file. SEC filing
- 2022-05-02 · Patel Priti: Larger than 46 of the 51 other insider sales of Common Stock on file. SEC filing
- 2021-03-17 · Ho Robert: Larger than 47 of the 51 other insider sales of Common Stock on file. SEC filing
- 2020-07-07 · BAKER JULIAN: Larger than 46 of the 48 other insider purchases of Common Stock on file. SEC filing
- 2020-04-02 · Redmile Group, LLC: Larger than 50 of the 51 other insider sales of Common Stock on file. SEC filing
- 2020-04-01 · Redmile Group, LLC: Larger than 49 of the 51 other insider sales of Common Stock on file. SEC filing
- 2019-12-20 · BAKER JULIAN: Larger than all 48 other insider purchases of Common Stock on file. SEC filing
- 2019-12-20 · BAKER JULIAN: Larger than 45 of the 48 other insider purchases of Common Stock on file. SEC filing
- 2019-08-07 · BAKER JULIAN: Larger than 44 of the 48 other insider purchases of Common Stock on file. SEC filing
Independent insiders buying near the same time
- 2024-11-22–2024-11-26: 6 event(s) across 3 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing , filing )
- 2019-12-20–2019-12-20: 3 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing )
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-05-06 | Cvijic Christine Mikail · President and CFO | Common Stock | S — Open market or private sale | −4,800 | 32.44 | SEC filing |
| 2026-05-06 | Cvijic Christine Mikail · President and CFO | Common Stock | S — Open market or private sale | −4,800 | 30.07 | SEC filing |
| 2026-03-26 | McMinn Rachel · Chief Executive Officer | Common Stock | S — Open market or private sale | −3,352 | 22.07 | SEC filing |
| 2026-03-26 | Jordan Julie · Chief Medical Officer | Common Stock | S — Open market or private sale | −828 | 21.89 | SEC filing |
| 2026-03-26 | Cvijic Christine Mikail · President and CFO | Common Stock | S — Open market or private sale | −2,558 | 21.62 | SEC filing |
| 2026-03-13 | Cobb Stuart · Chief Scientific Officer | Common Stock | S — Open market or private sale | −3,991 | 20.41 | SEC filing |
| 2026-03-13 | Cobb Stuart · Chief Scientific Officer | Common Stock | S — Open market or private sale | −148 | 22.08 | SEC filing |
| 2026-03-13 | Cvijic Christine Mikail · President and CFO | Common Stock | S — Open market or private sale | −2,387 | 20.42 | SEC filing |
Showing 8 of 20 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-05-05 | Shafer Christina · Chief Commercial Officer | Non-Qualified Stock Option (right to buy) | A — Grant, award, or other acquisition | +120,000 | SEC filing |
| 2026-02-20 | Jordan Julie · Chief Medical Officer | Common Stock | A — Grant, award, or other acquisition | +4,900 | SEC filing |
| 2026-02-20 | Woods Keith · Director | Non-Qualified Stock Option (right to buy) | A — Grant, award, or other acquisition | +12,050 | SEC filing |
| 2026-02-20 | Freedland Cory S. · Director | Non-Qualified Stock Option (right to buy) | A — Grant, award, or other acquisition | +12,050 | SEC filing |
| 2026-02-20 | Cvijic Christine Mikail · President and CFO | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +131,900 | SEC filing |
| 2026-02-20 | McMinn Rachel · Chief Executive Officer | Common Stock | A — Grant, award, or other acquisition | +25,900 | SEC filing |
| 2026-02-20 | BAFFI ROBERT · Director | Non-Qualified Stock Option (right to buy) | A — Grant, award, or other acquisition | +12,050 | SEC filing |
| 2026-02-20 | Noonberg Sarah B. · Director | Non-Qualified Stock Option (right to buy) | A — Grant, award, or other acquisition | +12,050 | SEC filing |
Showing 8 of 22 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2019-12-20 | BAKER JULIAN · Director | Common Stock | D — Disposition to the issuer | −1,160,148 | SEC filing |
| 2019-12-20 | BAKER JULIAN · Director | Common Stock | D — Disposition to the issuer | −9,765,333 | SEC filing |
Showing 2 of 2 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.